These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30626912)

  • 1. New roles for dopamine D
    Farino ZJ; Morgenstern TJ; Maffei A; Quick M; De Solis AJ; Wiriyasermkul P; Freyberg RJ; Aslanoglou D; Sorisio D; Inbar BP; Free RB; Donthamsetti P; Mosharov EV; Kellendonk C; Schwartz GJ; Sibley DR; Schmauss C; Zeltser LM; Moore H; Harris PE; Javitch JA; Freyberg Z
    Mol Psychiatry; 2020 Sep; 25(9):2070-2085. PubMed ID: 30626912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.
    Bono F; Savoia P; Guglielmi A; Gennarelli M; Piovani G; Sigala S; Leo D; Espinoza S; Gainetdinov RR; Devoto P; Spano P; Missale C; Fiorentini C
    Mol Neurobiol; 2018 Feb; 55(2):1054-1067. PubMed ID: 28092083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.
    Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM
    Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D
    Wei H; Zapata RC; Lopez-Valencia M; Aslanoglou D; Farino ZJ; Benner V; Osborn O; Freyberg Z; McCarthy MJ
    Psychoneuroendocrinology; 2020 Mar; 113():104551. PubMed ID: 31884319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion.
    Rubí B; Ljubicic S; Pournourmohammadi S; Carobbio S; Armanet M; Bartley C; Maechler P
    J Biol Chem; 2005 Nov; 280(44):36824-32. PubMed ID: 16129680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T
    Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance.
    García-Tornadú I; Ornstein AM; Chamson-Reig A; Wheeler MB; Hill DJ; Arany E; Rubinstein M; Becu-Villalobos D
    Endocrinology; 2010 Apr; 151(4):1441-50. PubMed ID: 20147524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity, non-selective attention and emotionality in dopamine D2/D3 receptor knock-out mice.
    Vallone D; Pignatelli M; Grammatikopoulos G; Ruocco L; Bozzi Y; Westphal H; Borrelli E; Sadile AG
    Behav Brain Res; 2002 Mar; 130(1-2):141-8. PubMed ID: 11864730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylation on the carboxyl terminus tail is required for the selective regulation of dopamine D2 versus D3 receptors.
    Zhang X; Le HT; Zhang X; Zheng M; Choi BG; Kim KM
    Biochim Biophys Acta; 2016 Sep; 1858(9):2152-2162. PubMed ID: 27349735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of dopamine D
    Liu XY; Zheng LF; Fan YY; Shen QY; Qi Y; Li GW; Sun Q; Zhang Y; Feng XY; Zhu JX
    Am J Physiol Cell Physiol; 2022 Mar; 322(3):C327-C337. PubMed ID: 34986020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for foregut tyrosine metabolism in glucose tolerance.
    Korner J; Cline GW; Slifstein M; Barba P; Rayat GR; Febres G; Leibel RL; Maffei A; Harris PE
    Mol Metab; 2019 May; 23():37-50. PubMed ID: 30876866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2-Like Receptors Mediate Dopamine-Inhibited Insulin Secretion via Ion Channels in Rat Pancreatic β-Cells.
    Liu M; Ren L; Zhong X; Ding Y; Liu T; Liu Z; Yang X; Cui L; Yang L; Fan Y; Liu Y; Zhang Y
    Front Endocrinol (Lausanne); 2020; 11():152. PubMed ID: 32318020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective D
    Manvich DF; Petko AK; Branco RC; Foster SL; Porter-Stransky KA; Stout KA; Newman AH; Miller GW; Paladini CA; Weinshenker D
    Neuropsychopharmacology; 2019 Jul; 44(8):1445-1455. PubMed ID: 30879021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine synthesis and D3 receptor activation in pancreatic β-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations.
    Ustione A; Piston DW
    Mol Endocrinol; 2012 Nov; 26(11):1928-40. PubMed ID: 22918877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged dopamine D
    Luis-Ravelo D; Fumagallo-Reading F; Castro-Hernandez J; Barroso-Chinea P; Afonso-Oramas D; Febles-Casquero A; Cruz-Muros I; Salas-Hernandez J; Mesa-Infante V; Rodriguez-Nuñez J; Gonzalez-Hernandez T
    Pharmacol Res; 2021 Mar; 165():105434. PubMed ID: 33484816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral-mediated gene delivery reveals distinct roles of nucleus accumbens dopamine D2 and D3 receptors in novelty- and light-induced locomotor activity.
    Fernandes AR; Easton AC; De Souza Silva MA; Schumann G; Müller CP; Desrivières S
    Eur J Neurosci; 2012 Apr; 35(8):1344-53. PubMed ID: 22394078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors.
    Aslanoglou D; Bertera S; Sánchez-Soto M; Benjamin Free R; Lee J; Zong W; Xue X; Shrestha S; Brissova M; Logan RW; Wollheim CB; Trucco M; Yechoor VK; Sibley DR; Bottino R; Freyberg Z
    Transl Psychiatry; 2021 Feb; 11(1):59. PubMed ID: 33589583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro.
    Simpson N; Maffei A; Freeby M; Burroughs S; Freyberg Z; Javitch J; Leibel RL; Harris PE
    Mol Endocrinol; 2012 Oct; 26(10):1757-72. PubMed ID: 22915827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.
    de Leeuw van Weenen JE; Parlevliet ET; Maechler P; Havekes LM; Romijn JA; Ouwens DM; Pijl H; Guigas B
    Biochem Pharmacol; 2010 Jun; 79(12):1827-36. PubMed ID: 20138024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice.
    Doherty JM; Masten VL; Powell SB; Ralph RJ; Klamer D; Low MJ; Geyer MA
    Neuropsychopharmacology; 2008 Oct; 33(11):2648-56. PubMed ID: 18075489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.